ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

In this article, we take a deeper look at Sheikh Hasina’s educational background, exploring how her studies have influenced her political career. As Bangladesh goes through these challenges, looking ...

Mitesh Sinha is a technology strategy leader with over two decades of experience spanning eCommerce, marketplaces, ...

If you're hosting a Holi party at home, these easy, vibrant cocktails are the perfect way to add a splash of colour ...

Predict dynamic behaviors in a physics system in a way that's computationally efficient and adaptable to a range of scenarios.

AI will be at Zellerbach Hall on June 5 to deliver insights into Artificial Intelligence through expert-led main-stage and breakout sessions, and networking opportunities.

For college athletes with concussion, brain changes may remain visible in brain scans up to a year after they are cleared to return to play, according to a study published on March 12, 2025, online in ...

Godox has announced its new ML100R, a full-color successor of the ML100Bi. It features the same lightweight design, but it comes with more portable ...

The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

According to NIST, HQC is built on a different math problem, which encryption systems use as a shield. While ML-KEM is based ...

Scale Integrated Photonic Device Platform for Energy-Efficient AI/ML Accelerators” was published by researchers at HP Labs, ...